
The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.
COVID-19 Related Technologies Ready for Commercialization
Diagnostics

Point-of-Care-Testing for COVID-19
Ultra-rapid (<5 minutes), highly-sensitive, and highly-specific detection of COVID-19 (TET-VirusDX), that is both cost-effective and easy to use. Read more
Therapeutics

Tunable, Anti-inflammatory Immune Responsive Biomaterials for COVID-19 Treatment
A platform of anti-inflammatory polymeric biomaterials that provides tunable immune responses via the modulation of macrophage metabolism. Read more

Novel Drug Use to Treat and Prevent COVID-19
Novel drug use and drug screening system for SARS-CoV-2 therapies. Read more

Therapies to treat COVID-19
Drug candidates to treat COVID-19 and a high throughput drug screening platform. Read more
Personal Protective Equipment (PPE)

Drinking Mask with Protection against Respiratory Illnesses
Protective mask (N-95, surgical, cloth, etc.) combined with an HME filter for safe drinking with others when social distancing is not possible. Read more
View All Available Cornell Technologies
Connect With a Member of the Licensing and Business Development Team